BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 38437637)

  • 1. Chronic Stress Dampens Lactobacillus Johnsonii-Mediated Tumor Suppression to Enhance Colorectal Cancer Progression.
    Cao Q; Zhao M; Su Y; Liu S; Lin Y; Da H; Yue C; Liu Y; Jing D; Zhao Q; Liu N; Du J; Zuo Z; Fu Y; Chen A; Birnbaumer L; Yang Y; Dai B; Gao X
    Cancer Res; 2024 Mar; 84(5):771-784. PubMed ID: 38190716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of Colorectal Cancer by Anthocyanidins and Mitigation of Metabolic Shifts Induced by Dysbiosis of the Gut Microbiome.
    Mudd AM; Gu T; Munagala R; Jeyabalan J; Egilmez NK; Gupta RC
    Cancer Prev Res (Phila); 2020 Jan; 13(1):41-52. PubMed ID: 31796466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocked conversion of Lactobacillus johnsonii derived acetate to butyrate mediates copper-induced epithelial barrier damage in a pig model.
    Wen Y; Yang L; Wang Z; Liu X; Gao M; Zhang Y; Wang J; He P
    Microbiome; 2023 Sep; 11(1):218. PubMed ID: 37777765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts.
    Zhang Z; Shao S; Zhang Y; Jia R; Hu X; Liu H; Sun M; Zhang B; Li Q; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110916. PubMed ID: 33113425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt-β-Catenin-IL-10 Signaling Axis in Intestinal APCs Protects Mice from Colitis-Associated Colon Cancer in Response to Gut Microbiota.
    Swafford D; Shanmugam A; Ranganathan P; Manoharan I; Hussein MS; Patel N; Sifuentes H; Koni PA; Prasad PD; Thangaraju M; Manicassamy S
    J Immunol; 2020 Oct; 205(8):2265-2275. PubMed ID: 32917787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stressing Out Cancer: Chronic Stress Induces Dysbiosis and Enhances Colon Cancer Growth.
    McCollum SE; Shah YM
    Cancer Res; 2024 Mar; 84(5):645-647. PubMed ID: 38437637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gut microbiota in the development of colorectal cancer: a review.
    Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
    Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
    Malla RR
    Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.